These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 22824293

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.
    Wang S, Huang J, Lyu H, Cai B, Yang X, Li F, Tan J, Edgerton SM, Thor AD, Lee CK, Liu B.
    Breast Cancer Res; 2013; 15(5):R101. PubMed ID: 24168763
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFκB signaling in HER2-overexpressing breast cancer cells.
    Seo HS, Choi HS, Kim SR, Choi YK, Woo SM, Shin I, Woo JK, Park SY, Shin YC, Ko SG.
    Mol Cell Biochem; 2012 Jul; 366(1-2):319-34. PubMed ID: 22527937
    [Abstract] [Full Text] [Related]

  • 25. 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.
    Zhao Q, Bi Y, Zhong J, Li X, Guo J, Liu YX, Pan LR, Tan Y, Deng ZS, Yu XJ.
    Acta Pharmacol Sin; 2021 May; 42(5):791-800. PubMed ID: 32868906
    [Abstract] [Full Text] [Related]

  • 26. Induction of caspase-dependent apoptosis by apigenin by inhibiting STAT3 signaling in HER2-overexpressing MDA-MB-453 breast cancer cells.
    Seo HS, Ku JM, Choi HS, Woo JK, Jang BH, Shin YC, Ko SG.
    Anticancer Res; 2014 Jun; 34(6):2869-82. PubMed ID: 24922650
    [Abstract] [Full Text] [Related]

  • 27. Differential induction of apoptosis in human breast cancer cell lines by phenethyl isothiocyanate, a glutathione depleting agent.
    Syed Alwi SS, Cavell BE, Donlevy A, Packham G.
    Cell Stress Chaperones; 2012 Sep; 17(5):529-38. PubMed ID: 22351438
    [Abstract] [Full Text] [Related]

  • 28. A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.
    Singel SM, Cornelius C, Batten K, Fasciani G, Wright WE, Lum L, Shay JW.
    Clin Cancer Res; 2013 Apr 15; 19(8):2061-70. PubMed ID: 23479679
    [Abstract] [Full Text] [Related]

  • 29. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
    Liu CY, Su JC, Ni MH, Tseng LM, Chu PY, Wang DS, Tai WT, Kao YP, Hung MH, Shiau CW, Chen KF.
    Breast Cancer Res Treat; 2014 Jul 15; 146(1):71-84. PubMed ID: 24903225
    [Abstract] [Full Text] [Related]

  • 30. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N, Chattopadhyay M, Rodes DB, Nazarenko A, Kodela R, Kashfi K.
    Molecules; 2015 Jul 09; 20(7):12481-99. PubMed ID: 26184135
    [Abstract] [Full Text] [Related]

  • 31. Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.
    Gründker C, Föst C, Fister S, Nolte N, Günthert AR, Emons G.
    Breast Cancer Res; 2010 Jul 09; 12(4):R49. PubMed ID: 20630060
    [Abstract] [Full Text] [Related]

  • 32. Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2+ Breast Cancer Cells to 5-Fluorouracil.
    Yi J, Chen S, Yi P, Luo J, Fang M, Du Y, Zou L, Fan P.
    Oncol Res; 2020 Dec 10; 28(5):519-531. PubMed ID: 32727638
    [Abstract] [Full Text] [Related]

  • 33. Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth.
    Chen J, Kinoshita T, Sukbuntherng J, Chang BY, Elias L.
    Mol Cancer Ther; 2016 Dec 10; 15(12):2835-2844. PubMed ID: 27678331
    [Abstract] [Full Text] [Related]

  • 34. ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells.
    Nautiyal J, Yu Y, Aboukameel A, Kanwar SS, Das JK, Du J, Patel BB, Sarkar FH, Rishi AK, Mohammad RM, Majumdar AP.
    Mol Cancer Ther; 2010 Jun 10; 9(6):1503-14. PubMed ID: 20515951
    [Abstract] [Full Text] [Related]

  • 35. Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation.
    Satyan KS, Swamy N, Dizon DS, Singh R, Granai CO, Brard L.
    Gynecol Oncol; 2006 Oct 10; 103(1):261-70. PubMed ID: 16624391
    [Abstract] [Full Text] [Related]

  • 36. Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells.
    Lee S, Yang W, Lan KH, Sellappan S, Klos K, Hortobagyi G, Hung MC, Yu D.
    Cancer Res; 2002 Oct 15; 62(20):5703-10. PubMed ID: 12384528
    [Abstract] [Full Text] [Related]

  • 37. Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.
    Xiao D, Singh SV.
    Pharm Res; 2010 Apr 15; 27(4):722-31. PubMed ID: 20182772
    [Abstract] [Full Text] [Related]

  • 38. Combination therapy of RY10-4 with the γ-secretase inhibitor DAPT shows promise in treating HER2-amplified breast cancer.
    Su F, Zhu S, Ruan J, Muftuoglu Y, Zhang L, Yuan Q.
    Oncotarget; 2016 Jan 26; 7(4):4142-54. PubMed ID: 26716652
    [Abstract] [Full Text] [Related]

  • 39. Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin.
    Jandial DD, Krill LS, Chen L, Wu C, Ke Y, Xie J, Hoang BH, Zi X.
    Molecules; 2017 Mar 14; 22(3):. PubMed ID: 28335434
    [Abstract] [Full Text] [Related]

  • 40. Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells.
    Ferreira RB, Wang M, Law ME, Davis BJ, Bartley AN, Higgins PJ, Kilberg MS, Santostefano KE, Terada N, Heldermon CD, Castellano RK, Law BK.
    Oncotarget; 2017 Apr 25; 8(17):28971-28989. PubMed ID: 28423644
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.